P1‐038: VERUBECESTAT PHARMACOKINETIC AND EXPOSURE‐RESPONSE RESULTS FROM EPOCH: A PHASE 3 TRIAL IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE
| Autor: | Julie A. Stone, Ming Xu, Mike F. Egan, David J. Jaworowicz, Marissa F. Dockendorf, Rebecca Humphrey, Christian Rasmussen, Tiffini Voss, Huub Jan Kleijn |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Epidemiology business.industry Health Policy Phase (waves) Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Pharmacokinetics Internal medicine medicine Cardiology Verubecestat Neurology (clinical) EPOCH (chemotherapy) Geriatrics and Gerontology business Exposure response |
| Zdroj: | Alzheimer's & Dementia. 14 |
| ISSN: | 1552-5279 1552-5260 |
| DOI: | 10.1016/j.jalz.2018.06.039 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|